Printer Friendly

CEPHEID GETS PATENT COVERING I-CORE REACTION VESSEL.

Cepheid (Nasdaq: CPHD), Sunnyvale, Calif., has announced the issuance of U.S. Patent No. 6,403,037 covering a novel reaction vessel for use in the company's I-CORE(R) DNA amplification and detection modules. Designed to allow for automated handling of genetic material, the vessel can be filled with reaction fluid and sealed using conventional high-throughput pipetting equipment. The technology embodied in the patent enables application of the basic I-CORE module to high-throughput test systems.

I-CORE Technology

The integrated, cooling/ heating optics reaction module, or I-CORE module, is the basic building block for Cepheid's automated DNA detection and analysis platforms. The module is a complete, independent, temperature-controlled fluorimeter for performing and continuously monitoring amplification of DNA or other nucleic acid targets. Cepheid's proprietary I-CORE module enables rapid amplification and optical detection of multiple DNA targets to be carried out simultaneously in a single, closed reaction tube.

Cepheid, based in Sunnyvale, Calif., is a leading developer, manufacturer and marketer of miniaturized, fully integrated systems for rapid, on-site detection of DNA -- the universal biological identifier. Founded in 1996, the company is commercializing its technology and products for scientific, medical and industrial applications requiring time-critical detection of human and other genes, infectious disease agents, and industrial and environmental contaminants at the point of need.

For more information, call 408/541-4191 or visit http://www.cepheid.com.
COPYRIGHT 2002 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Comment:CEPHEID GETS PATENT COVERING I-CORE REACTION VESSEL.
Publication:Biotech Equipment Update
Geographic Code:1USA
Date:Aug 1, 2002
Words:223
Previous Article:GUIDANT REPORTS EXCELLENT RESULTS FOR ELUTING STENT TRIAL.
Next Article:CEPHEID GETS ISO 9001 CERTIFICATION.
Topics:


Related Articles
Myriad Genetics awarded United States patent for DNA sequencing.
CEPHEID DELIVERS FIRST PROTOTYPE OF GENEXPERT TO USAMRIID.
BUCHER BIOTEC NOW SWISS DISTRIBUTOR OF CEPHEID SMART CYCLER.
CEPHEID GETS ISO 9001 CERTIFICATION.
Applied bio gets injunction against Bio-Rad and grants Cepheid license.
The bottom line.
Cepheid awarded patents for ultrasonic lysis and sample preparation technology.
The bottom line.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters